Abstract: The present invention discloses a novel antibody HES5:3:3 directed towards a specific antigen present on human pluripotent stem (hPS) cells and cancer tissue. The antibody can be used as a tool for human pluripotent stem (hPS) cell applications, such as the separation, surface adhesion and enhanced survival of said hPS cells. Furthermore, the present invention refers to the use of the antigen detection for cancer applications.

Abstract: The present invention relates to monoclonal antibodies capable of distinguishing squamous cell cancer antigens, SCCA, in either free or complex bound forms, preferably antigens SCCA1 and SCCA2, as well as hybridomas recognizing such antibodies, method for diagnosing SCC, as well as diagnostic kits for detecting SCCAs.

Abstract: The present invention relates to a method for establishment of antibodies with specificity for high-risk HPVs compared to immunization using the whole antigen of high-risk HPVs, wherein the method includes an exclusion of evolutionary conserved motifs as well as regions with high similarity to E7 proteins of low-risk HPVs, as well as thus obtained antibodies.

Abstract: The present invention relates to monoclonal antibodies capable of distinguishing squamous cell cancer antigens, SCCA, in either free or complex bound forms, preferably antigens SCCA1 and SCCA2, as well as hybridomas recognizing such antibodies, method for diagnosing SCC, as well as diagnostic kits for detecting SCCAs.

Abstract: The present invention relates to novel monoclonal antibodies against the calcium binding protein S100, the use of these antibodies for the development of immunoassays for specific determination of total S100 or the different isoforms of S100 in serum, plasma, cerebrospinal fluid and other body fluids.

Abstract: For the immunological determination of PSA-ACT complexes in a sample to be examined in which the sample is contacted with at least one antibody that specifically binds the complexes or their components or with specifically binding fragments thereof in which the antibody is bound to a solid phase or can be bound to a solid phase, a test liquid is used according to the invention which contains 0.5 to 2.5 mol/l of an alkali chloride at least during contact between the sample and the solid phase. A buffer system according to the invention for a PSA-ACT test contains 0.5 to 2.5 mol/l, preferably 1.5 to 2.0 mol/l alkali chloride in addition to other common buffer substances.

Abstract: An optical amplifying device for amplification of an optical signal incident to a photo diode comprises a laser device and an electrical feeding circuit. The laser device is so formed that it comprises one single laser device comprising a number of active regions or laser structures electrically connected in series within one and the same optical cavity.

Abstract: A surface emitting laser device with at least two active regions in one and the same optical, vertical cavity wherein the active regions are electrically connected in series.

Abstract: An edge emitting laser device with at least two laser structures arranged in one and the same optical cavity. The laser structures are substantially arranged in the optical direction of propagation and each laser structure comprises an active region, said active regions being electrically connected in series.

Abstract: An arrangement e.g. for image generation and/or reading has first and second light element arranged substantially in two dimensions, control and addressing devices for activation of light or picture elements wherein at least the first light elements are real and form a thin matrix and the second light elements form a denser matrix wherein the position of each first light element at a given time corresponds to the position of a second light element. The addressing devices are spatially arranged or connected to at least each first element, and first as well as second light or picture elements are activated via said control and addressing devices.

Abstract: A device for establishing the magnitude of irregularities at a surface includes a laser directing a beam of light, obliquely towards said surface, a photodetector mounted so as to catch a beam of light reflected from an irregularity at said surface, and a diffraction grating mounted in the path of a beam, mirror-image reflected from said surface and movable in relation thereto. The photodetector is provided with means for measuring the frequency and the amplitude of the time-dependent photocurrent caused by the interaction between the beam reflected from the irregularity and a further beam deflected by the diffraction grating from the mirror-image reflected beam.In a modified version the device may be used for measuring flow velocity, the laser and the photodetector being mounted to opposite sides of a flow path defined by transparent walls.

Abstract: A galvanic primary cell in which complexing agents are supplied to the anode and/or the cathode to eliminate operation-inhibiting or passivating phase interfaces, such as a passivating coating on the anode or a heterogeneous supply of active material inhibiting the cathode reaction. More particularly, in an iron/air cell, complexing agents for iron are supplied to eliminate coatings on the Fe-anode, while complexing agents for oxygen are supplied to reversibly dissolve O.sub.2 at the cathode.